Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Di Giorgio

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Handbook of Experimental Pharmacology|June 16, 2019
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver DisordersStefano Fiorucci, Cristina Di Giorgio, Eleonora Distrutti
Cells|October 15, 2024
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future DevelopmentsStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Cells|September 27, 2024
Current Landscape and Evolving Therapies for Primary Biliary CholangitisStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Progress in Lipid Research|August 9, 2024
Immunology of bile acids regulated receptorsStefano Fiorucci, Silvia Marchianò, Ginevra Urbani, et al.
Cells|June 2, 2021
Bile Acids Activated Receptors in Inflammatory Bowel DiseaseMichele Biagioli, Silvia Marchianò, Adriana Carino, et al.
Nutrients|July 8, 2020
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal InflammationMichele Biagioli, Adriana Carino, Cristina Di Giorgio, et al.
Recent Advances in Inflammation & Allergy Drug Discovery|January 6, 2022
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesisCristina Di Giorgio, Rosalinda Roselli, Michele Biagioli, et al.
Recent Advances in Inflammation & Allergy Drug Discovery|November 22, 2022
Modeling Inflammatory Bowel Disease by Intestinal OrganoidsCristina Di Giorgio, Rosalinda Roselli, Michele Biagioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2020
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver ToxicityMichele Biagioli, Adriana Carino, Chiara Fiorucci, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 4, 2021
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signalingSilvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Handbook of Experimental Pharmacology|June 16, 2019
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver DisordersStefano Fiorucci, Cristina Di Giorgio, Eleonora Distrutti
Cells|October 15, 2024
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future DevelopmentsStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Cells|September 27, 2024
Current Landscape and Evolving Therapies for Primary Biliary CholangitisStefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Progress in Lipid Research|August 9, 2024
Immunology of bile acids regulated receptorsStefano Fiorucci, Silvia Marchianò, Ginevra Urbani, et al.
Cells|June 2, 2021
Bile Acids Activated Receptors in Inflammatory Bowel DiseaseMichele Biagioli, Silvia Marchianò, Adriana Carino, et al.
Nutrients|July 8, 2020
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal InflammationMichele Biagioli, Adriana Carino, Cristina Di Giorgio, et al.
Recent Advances in Inflammation & Allergy Drug Discovery|January 6, 2022
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesisCristina Di Giorgio, Rosalinda Roselli, Michele Biagioli, et al.
Recent Advances in Inflammation & Allergy Drug Discovery|November 22, 2022
Modeling Inflammatory Bowel Disease by Intestinal OrganoidsCristina Di Giorgio, Rosalinda Roselli, Michele Biagioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2020
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver ToxicityMichele Biagioli, Adriana Carino, Chiara Fiorucci, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 4, 2021
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signalingSilvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Pageof 5